Training Programs for Improving Provider Support in Tobacco Cessation

Overseen By Ashley Clawson, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Arkansas

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help healthcare providers better support people who want to quit smoking. It seeks to improve how providers advise on quitting tobacco and refer patients for early lung cancer screenings. The trial compares two training approaches: one focuses solely on smoking and lung cancer, while the other includes additional training from a global lung cancer center. Providers who are members of the National Medical Association, serve Black patients who smoke, and have time for clinical care are well-suited for this trial. As an unphased study, this trial offers a unique opportunity to contribute to innovative strategies that could enhance patient care and smoking cessation support.

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

What prior data suggests that these training programs are safe for healthcare providers?

Research has shown that smoking cessation programs tailored to cultural needs are both popular and practical for participants. These programs often help individuals adhere to treatments like nicotine patches or gum.

For the Health Disparities and Lung Cancer Screening training, studies have found that combining smoking cessation support with lung cancer screening is effective. Programs offering both counseling and quitting aids, such as nicotine patches or gum, have successfully helped many people quit smoking.

While these studies focus on program effectiveness, they also indicate that participants generally tolerate the treatments well. No major safety issues have been reported, making it a promising option for those considering related clinical trials. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about these training programs because they aim to enhance healthcare providers' knowledge and support in tobacco cessation, particularly for Black communities who face significant health disparities. Unlike standard online courses, the "Quit and Screen Project" training is culturally tailored, addressing specific gaps in understanding lung cancer screening and smoking cessation. Additionally, the combination of this training with the G02 Lung Cancer Screening training offers a comprehensive approach, potentially leading to more effective provider support and better health outcomes for patients.

What evidence suggests that these training programs are effective for improving provider support in tobacco cessation?

This trial will compare different training programs for healthcare providers to enhance support in tobacco cessation. Research has shown that smoking cessation programs tailored to specific cultural groups can aid individuals in quitting smoking. For African American adults, combining counseling and medication effectively reduces tobacco use. Additionally, culturally specific methods, such as targeted videos, have improved success rates for participants in quitline programs.

Regarding lung cancer screening, studies have demonstrated that quitting smoking significantly lowers the risk of lung cancer and death. One study found that combining lung cancer screening with smoking cessation support can significantly reduce lung cancer deaths. This approach may help address disparities in health outcomes related to race, income, and location. In this trial, providers will complete either the Quit and Screen Project training alone or in combination with the G02 Lung Cancer Screening training to evaluate the effectiveness of these educational interventions. ^{1 2 6 7 8}

Who Is on the Research Team?

Mignonne Guy, PhD

Principal Investigator

Virginia Commonwealth University

Pebbles Fagan, PhD, MPH

Principal Investigator

University of Arkansas

Ashley Clawson, PhD

Principal Investigator

University of Arkansas

Are You a Good Fit for This Trial?

This trial is for Black healthcare providers. It aims to empower them to assist Black smokers in quitting, particularly menthol cigarettes and flavored cigars, and encourage early lung cancer screening.

Inclusion Criteria

I can refer smokers to a patient navigator.

Currently screens clients for tobacco use in the clinic

Will provide contact email, address and phone.

Exclusion Criteria

Not applicable.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Training

Providers complete online training modules, including pre- and post-tests to assess knowledge, attitudes, and behavioral intentions.

1 day

Online training session

Follow-up

Participants are monitored for retention and adherence to training modules, and feedback is collected.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Black Health Block Culturally Tailored training
• Health Disparities and Lung Cancer Screening training

Trial Overview The study tests two training modules: one on cultural tailoring called the 'Black Health Block Culturally Tailored Training' and another combined with 'Health Disparities and Lung Cancer Screening Training'. Providers are randomly assigned to either module to see which better improves their advice on quitting smoking and lung cancer screening referrals.

How Is the Trial Designed?

Group I: Quit and Screen Project training alone Experimental Treatment 1 Intervention

Providers in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training .

Group II: Quit and Screen Project training + G02 Lung Cancer Screening training Experimental Treatment 2 Interventions

In this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training.

Who Is Running the Clinical Trial?

University of Arkansas

Lead Sponsor

Trials

500

Recruited

153,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials

473

Recruited

1,374,000+

Virginia Commonwealth University

Collaborator

Trials

732

Recruited

22,900,000+

Coalition for a Tobacco Free Arkansas

Collaborator

Trials

3

Recruited

640+

National Medical Association

Collaborator

Trials

1

Recruited

300+

Published Research Related to This Trial

Approximately 45% of cancer patients had missing tobacco use history in their electronic medical records, highlighting a significant gap in screening that could affect treatment outcomes.

Stakeholders expressed a strong interest in improving tobacco screening and cessation services, but identified barriers such as cultural differences, time constraints, and lack of training, indicating a need for tailored interventions to enhance tobacco cessation efforts among diverse patient populations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Implementation planning for equitable tobacco treatment services: a mixed methods assessment of contextual facilitators and barriers in a large comprehensive cancer center. Tsui, J., Sloan, K., Sheth, R., et al.[2023]

Lung cancer screening (LCS) is effective in reducing lung cancer mortality among high-risk smokers, but its adoption is limited, especially among racially and ethnically minoritized groups, highlighting a significant health disparity.

Interventions that streamlined the LCS process at clinics were found to be the most effective, while community-level efforts focused on education showed promise in engaging minoritized populations, indicating a need for more targeted research and standardized outcomes in future studies.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Interventions to improve lung cancer screening among racially and ethnically minoritized groups: A scoping review. Nam, J., Krishnan, G., Shofer, S., et al.[2023]

A systematic review of 21 studies revealed significant disparities in lung cancer screening (LCS) outcomes for Black and socioeconomically disadvantaged individuals, highlighting that these groups often miss out on the benefits of LCS, which contributes to higher mortality rates from nonsmall cell lung cancer (NSCLC).

The study identified critical areas of inequity in the LCS pipeline, including eligibility criteria, utilization, and follow-up care, and recommends further research and targeted interventions to improve access and outcomes for marginalized populations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review. Sosa, E., D'Souza, G., Akhtar, A., et al.[2022]

Citations

1. sciencedirect.com sciencedirect.com/science/article/abs/pii/S0749379723002532

Enhancing Tobacco Quitline Outcomes for African ... This study tested the effectiveness of a culturally specific tobacco cessation video intervention among African American quitline enrollees.

2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC3712791/

Development of a Culturally Targeted Smoking Cessation ... Findings suggest that a culturally targeted and intensive group based smoking cessation treatment is plausibly effective in improving smoking cessation outcomes ...

3. ajpmonline.org ajpmonline.org/article/S0749-3797(23)00253-2/fulltext

Enhancing Tobacco Quitline Outcomes for African ... This study tested the effectiveness of a culturally specific tobacco cessation video intervention among African American quitline enrollees.

4. academic.oup.com academic.oup.com/tbm/article/13/10/775/7190774

efficacy of tobacco cessation treatment for African American ... Overall, tobacco cessation treatment that combines behavioral and pharmacological approaches decreases tobacco use for African American adults.

5. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov/38105395/

Effectiveness of culturally tailoring smoking cessation ... This systematic review measured the effectiveness of culturally tailoring smoking cessation interventions on quitting or reducing smoking combustible tobacco.

6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC3509015/

A Review of Culturally Targeted/Tailored Tobacco ... The overall findings indicated that culturally tailoring cessation interventions did not appear to improve tobacco quit rates among minority ...

7. bmcpublichealth.biomedcentral.com bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-5015-z

Effects of a culturally specific tobacco cessation intervention ... The goal of the present study is to test the effectiveness of adding a culturally specific, video-based, adjunct to standard quitline care.

8. sciencedirect.com sciencedirect.com/science/article/abs/pii/S0027968420304624

A Feasibility Study of Smoking Cessation Utilizing an ... This study fills a gap in the research by examining whether exercise enhance smoking cessation specifically among Black women. Culturally tailored comprehensive ...